scanance.
Sign inGet Premium
MA

Mativ Holdings, Inc.

MATVBasic MaterialsNASDAQ

Specialty Chemicals

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$1.99B
+0.3% YoY
Net Income
-$337.4M
-592.8% YoY
EBITDA
-$250.9M
-279.7% YoY
Free Cash Flow
$149.6M

Scan Results

Daily timeframe
DateIndicatorDetails
Loading...
About Mativ Holdings, Inc.

Part of the basic materials sector, Mativ Holdings, Inc. (MATV) is listed under Specialty Chemicals. With a market capitalization of $436.0M, it sits in small-cap territory. The company operates through two segments, Filtration & Advanced Materials and Sustainable & Adhesive Solutions.

Key stats
Market Cap$436.0M
P/E (TTM)5.61
Fwd P/E6.33
EPS$1.41
Beta0.88
52W Change+21.1%
Dividend Yield5.06%
ROE17.0%
Analysis

The company holds $82.3M in cash, though total debt stands at $1.10B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $149.6M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 17.0%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.1% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $1.64B (2022) to $1.99B (2025), reflecting a 21% increase over the period.

The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. No single metric tells the full story. Reviewing MATV's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms